Susquehanna Portfolio Strategies’s BioNTech BNTX Stock Holding History

Susquehanna Portfolio Strategies’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-76,027	Closed	-$6.76M	–	877
2026 Q1	$6.76M	Buy	76,027 +7,054	+10%	+$725K	0.1%	253
2025 Q4	$6.57M	Sell	68,973 -23,663	-26%	-$2.38M	0.1%	262
2025 Q3	$9.14M	Hold	92,636	–	–	0.14%	204
2025 Q2	$9.86M	Buy	92,636 +86,589	+1,432%	+$8.75M	0.22%	132
2025 Q1	$551K	Buy	+6,047	New	+$677K	0.24%	72

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Susquehanna Portfolio Strategies's BNTX Position: Q2 2026 in Review

Susquehanna Portfolio Strategies sold out of BioNTech (BNTX) in Q2 2026, closing a stake of 76,027 shares — an estimated $6.76M sold.

Susquehanna Portfolio Strategies first reported a position in BNTX in Q1 2025 and held it in 5 quarters. The position peaked at $9.86M in Q2 2025. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Susquehanna Portfolio Strategies reported no remaining BioNTech position as of Q2 2026 after selling out during the quarter.
Susquehanna Portfolio Strategies sold 76,027 BioNTech shares in Q2 2026, an estimated $6.76M.
Susquehanna Portfolio Strategies first reported a position in BioNTech in Q1 2025 and held it in 5 quarters.
Susquehanna Portfolio Strategies's BioNTech position peaked at $9.86M in Q2 2025.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.